News
Novo Nordisk Signs OpenAI Deal to Bring Medicines to Patients Faster
Ozempic maker says pilots will start across R&D, manufacturing and commercial operations, with full integration due by end-2026
Ozempic maker says pilots will start across R&D, manufacturing and commercial operations, with full integration due by end-2026
Researchers warn AI chatbots remain unreliable for medical advice, with studies showing they can repeat misinformation and provide confusing guidance to users seeking health information.
Speaking to MIT SMR India, Bargava Subramanian, Chief AI and Data Officer at 5C Network, a leading digital diagnostics platform in India, said, “For X-rays, the entire inference time is less than a minute. The AI can process and generate results within a few seconds.”